CME Group (NASDAQ:CME) Price Target Raised to $250.00

CME Group (NASDAQ:CME) had its price target raised by JPMorgan Chase & Co. from $249.00 to $250.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “underweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 1.38% from the stock’s current price.

Other research analysts have also issued research reports about the stock. UBS Group cut their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. The Goldman Sachs Group reduced their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $292.47.

CME Group Trading Up 1.7%

Shares of CME traded up $4.26 during trading hours on Thursday, hitting $253.50. The stock had a trading volume of 1,518,705 shares, compared to its average volume of 2,767,212. CME Group has a 12-month low of $218.31 and a 12-month high of $329.16. The firm has a market cap of $91.86 billion, a P/E ratio of 21.63, a P/E/G ratio of 2.95 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company’s fifty day simple moving average is $255.87 and its 200 day simple moving average is $281.51.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue was up .8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.96 earnings per share. Equities research analysts forecast that CME Group will post 12.17 EPS for the current fiscal year.

Insider Activity

In other news, Director William R. Shepard purchased 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. FLC Capital Advisors acquired a new stake in CME Group in the 4th quarter worth approximately $2,122,000. First Bank & Trust acquired a new position in CME Group during the fourth quarter valued at approximately $1,325,000. Mn Services Vermogensbeheer B.V. raised its position in shares of CME Group by 2.9% in the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 140,210 shares of the financial services provider’s stock valued at $38,289,000 after purchasing an additional 3,931 shares during the period. MOKAN Wealth Management Inc. raised its position in shares of CME Group by 138.8% in the fourth quarter. MOKAN Wealth Management Inc. now owns 7,144 shares of the financial services provider’s stock valued at $1,953,000 after purchasing an additional 4,152 shares during the period. Finally, HighTower Advisors LLC lifted its stake in shares of CME Group by 6.9% in the fourth quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock worth $96,376,000 after buying an additional 22,692 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group reported Q2 EPS of $2.99, beating estimates, while revenue of about $1.71 billion also topped expectations, highlighting resilient demand in its derivatives business. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which supports the bullish reaction. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Trading activity remained robust, with average daily volume near record levels and market data revenue reaching a record, both of which suggest durable demand across CME’s platform. CME Group (CME) Q2 Earnings and Revenues Top Estimates
• Neutral Sentiment: Several analysts reiterated mixed views after earnings: UBS maintained a Hold with a $260 target, while Bank of America kept a Sell despite raising its target, suggesting the stock may still face valuation questions. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.